Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 2Smoking Cessation 1Neoplasms, Second Primary 1Hand-Foot Syndrome 1Cigarette Smoking 1Chemotherapy-Related Cognitive Impairment 1Behavior, Addictive 1

Interventions

Tobacco Use Cessation Devices 1Sodium Chloride 1Mesna 1Electroacupuncture 1Doxorubicin 1Cyclophosphamide 1Ashwagandha 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Chemotherapy-Related Cognitive Impairment × Tobacco Use Cessation Devices × Clear all
NCT02312934 2020-01-21

Nicotinic Treatment of Post-Chemotherapy Subjective Cognitive Impairment: A Pilot Study

Vanderbilt University Medical Center

Phase 2 Completed
22 enrolled 14 charts
Breast

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡